Our core content on Lung conditions and related factsheets has been translated to a number of other languages.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
European Lung Foundation
Our core content on Lung conditions and related factsheets has been translated to a number of other languages by our volunteer team.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
A study has found that children who use certain types of inhalers to treat their asthma may grow slower than their peers.
The research, published by the Cochrane Collaboration, involved a review of 25 trials involving 8,471 children, to find out whether corticosteroid inhaler use affects the growth of children with asthma.
The researchers found that growth rates were cut by about half a centimetre on average during the first year of use.
However, many healthcare experts have argued that this side effect should be seen as “a small price to pay” for using a potentially life-saving medicine.
Sign up to our free monthly newsletter to get the latest information and research news on lung conditions, plus views from experts and patients! You can unsubscribe at any time.
ELF is a non-profit organisation registered as a UK company (VAT no. GB 115 0027 74) and charity (no. 1118930).
Our Brussels office enterprise number is 0738.383.695
European Lung Foundation's TR ID number in the Transparency Register is: 094039644810-79